At the 2018 Gastrointestinal Cancers Symposium, David Ilson, MD, PhD, from the Memorial Sloan Kettering Cancer Center talks about a different number of strategies to individualize treatment and about the recently completed HER2 Trial.
Multiple Strategies to Individualize Gastroesophageal Cancer Patients
